Keep it in its original container until you are ready to use it
These lumps can vary in size, shape, and texture
You feel less hungry, so you make better choices when you eat
The same mL volume can show a different unit number on different syringe scales
In May 2025, CVS Caremark announced that anti-obesity (AOM) tirzepatide (sold as Zepbound) would be removed from its preferred formulary effective July 1, 2025, with AOM semaglutide (sold as Wegovy) designated as the preferred alternative
Typical weightloss results on semaglutide, tirzepatide, and others Although typical weight-loss results on semaglutide, tirzepatide, and other GLP-1 medications can vary, both semaglutide and tirzepatide have been seen to help provide meaningful average weight loss